Bo Cumbo has nearly three decades of pharmaceutical and biotechnology industry experience, including commercial launches of 11 specialty or rare disease drugs. He is currently president, chief executive officer and board member of Solid Biosciences. Previously, Bo served as president and chief executive officer of AavantiBio, Inc. Prior to AavantiBio, he held leadership positions at Sarepta Therapeutics, Inc., most recently as the executive vice president and chief commercial officer. Previously, Bo served as vice president of sales, key account management, and treatment educator teams at Vertex Pharmaceuticals. Earlier in his career, he served in multiple commercial roles supporting the HIV, HBV, and cardiovascular franchises at Gilead Sciences.
Bo holds a B.S. in Laboratory Technology from Auburn University.